## **Core Concept**
Warfarin-induced skin necrosis is a rare but severe side effect of warfarin therapy, characterized by the necrosis of skin and subcutaneous tissue. This condition is associated with a deficiency of **protein C**, a vitamin K-dependent anticoagulant protein. The mechanism involves a transient hypercoagulable state due to the initial drop in protein C levels before the decrease in other vitamin K-dependent clotting factors.

## **Why the Correct Answer is Right**
The correct answer, **D.**, is related to the timing and mechanism of warfarin-induced skin necrosis. This condition typically occurs within the first few days of starting warfarin therapy, especially if high initial doses are used. The reason is that **protein C** has a shorter half-life (about 8-11 hours) compared to other vitamin K-dependent clotting factors (such as factors II, IX, and X). As warfarin inhibits vitamin K recycling, protein C levels drop first, leading to a temporary hypercoagulable state that can cause skin necrosis.

## **Why Each Wrong Option is Incorrect**
- **Option A:** Incorrect because warfarin-induced skin necrosis is not primarily related to the drug's effect on platelets.
- **Option B:** Incorrect as it does not accurately describe the mechanism or timing of warfarin-induced skin necrosis.
- **Option C:** Incorrect because while factor II (prothrombin) is affected by warfarin, the specific timing and mechanism of skin necrosis are more closely related to the imbalance caused by the drop in protein C levels.

## **Clinical Pearl / High-Yield Fact**
A key point to remember is that warfarin-induced skin necrosis often presents with **painful skin lesions**, typically on the breasts, thighs, or buttocks, usually within 3-8 days of starting warfarin. A high index of suspicion is crucial for early diagnosis. Management includes stopping warfarin and considering alternative anticoagulants.

## **Correct Answer:** . Protein C deficiency.